Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro.
暂无分享,去创建一个
K. Fong | I. Yang | P. Molenaar | M. West | F. Russell | S. Savarimuthu | G. Rabnott | Li Li
[1] L. Groop,et al. Polymorphism in the &bgr;1-Adrenergic Receptor Gene and Hypertension , 2001, Circulation.
[2] P. Insel,et al. In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. , 2001, Pharmacogenetics.
[3] R. Kim,et al. Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. , 2001, Pharmacogenetics.
[4] M. Börjesson,et al. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. , 2000, European heart journal.
[5] B. Fu,et al. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. , 2000, Clinical science.
[6] L. Tiret,et al. Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated Cardiomyopathy , 1999 .
[7] D. A. Mason,et al. A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor* , 1999, The Journal of Biological Chemistry.
[8] S. Ball,et al. Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay , 1999, The Lancet.
[9] T. Kayahara,et al. Anti‐thrombotic effects and bleeding risk of AJvW‐2, a monoclonal antibody against human von Willebrand factor , 1997, British journal of pharmacology.
[10] J. Arch,et al. Effects of (−)‐RO363 at human atrial β‐adrenoceptor subtypes, the human cloned β3‐adrenoceptor and rodent intestinal β3‐adrenoceptors , 1997 .
[11] S. Motomura,et al. Chronic β1‐adrenoceptor antagonist treatment sensitizes β2‐adrenoceptors, but desensitizes M2‐muscarinic receptors in the human right atrium , 1990, British journal of pharmacology.
[12] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[13] S. Jamieson,et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.
[14] R. Hetzer,et al. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? , 2000, Journal of molecular medicine.
[15] L. Tiret,et al. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. , 1999, Journal of molecular and cellular cardiology.
[16] J. Arch,et al. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. , 1997, British journal of pharmacology.
[17] M. Brown,et al. Selective j31-Adrenoceptor Blockade Enhances Positive Inotropic Responses toEndogenous Catecholamines Mediated Through j2-Adrenoceptors inHumanAtrial Myocardium , 1990 .